Current best practice for bladder cancer: a narrative review of diagnostics and treatments
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current best practice for bladder cancer: a narrative review of diagnostics and treatments
Authors
Keywords
-
Journal
LANCET
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-09-27
DOI
10.1016/s0140-6736(22)01188-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bladder EpiCheck for NMIBC
- (2022) Tim Thomas Nature Reviews Urology
- Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of the GETUG-AFU V05 VESPER Trial
- (2022) Christian Pfister et al. JOURNAL OF CLINICAL ONCOLOGY
- The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors
- (2022) George J. Netto et al. EUROPEAN UROLOGY
- Long term outcomes of radical radiotherapy with hypoxia modification with biomarker discovery for stratification: Ten year update of the BCON (Bladder CarbOgen Nicotinamide) phase III randomised trial (ISRCTN45938399)
- (2021) Yee Pei Song et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials
- (2021) Ananya Choudhury et al. LANCET ONCOLOGY
- Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial
- (2021) Joaquim Bellmunt et al. LANCET ONCOLOGY
- Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
- (2021) Thomas Powles et al. NEW ENGLAND JOURNAL OF MEDICINE
- TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors
- (2021) Scott T. Tagawa et al. JOURNAL OF CLINICAL ONCOLOGY
- Image-guided Adaptive Radiotherapy for Bladder Cancer
- (2021) V. Kong et al. CLINICAL ONCOLOGY
- Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
- (2021) Thomas Powles et al. LANCET ONCOLOGY
- Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
- (2021) Arjun V Balar et al. LANCET ONCOLOGY
- Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma
- (2021) Dean F. Bajorin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Performance of Narrow Band Imaging (NBI) and Photodynamic Diagnosis (PDD) Fluorescence Imaging Compared to White Light Cystoscopy (WLC) in Detecting Non-Muscle Invasive Bladder Cancer: A Systematic Review and Lesion-Level Diagnostic Meta-Analysis
- (2021) Giorgio I. Russo et al. Cancers
- Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?
- (2021) Nada Humayun-Zakaria et al. Translational Andrology and Urology
- International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin–exposed High-risk Non–muscle-invasive Bladder Cancer
- (2021) Mathieu Roumiguié et al. EUROPEAN UROLOGY
- Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials
- (2021) Sarah Burdett et al. EUROPEAN UROLOGY
- The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma
- (2021) Richard Cathomas et al. EUROPEAN UROLOGY
- NRG Oncology/RTOG 0926: Phase II Protocol for Patients With Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment by Radiation Therapy Concurrent With Radiosensitizing Chemotherapy Following a Thorough Transurethral Surgical Re-Staging
- (2021) D.M. Dahl et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Use of Vesical Imaging-Reporting and Data System (VI-RADS) for detecting the muscle invasion of bladder cancer: a diagnostic meta-analysis
- (2020) Cheng Luo et al. EUROPEAN RADIOLOGY
- European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
- (2020) J. Alfred Witjes et al. EUROPEAN UROLOGY
- Diagnostic accuracy of ultrasonography, computed tomography, cystoscopy and cytology to detect urinary tract malignancies in patients with asymptomatic hematuria
- (2020) Christian Daniel Fankhauser et al. WORLD JOURNAL OF UROLOGY
- The emerging role of antibody-drug conjugates in urothelial carcinoma
- (2020) Michael Lattanzi et al. Expert Review of Anticancer Therapy
- Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
- (2020) Thomas Powles et al. LANCET ONCOLOGY
- Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
- (2020) Thomas Powles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunotherapy in non-muscle-invasive bladder cancer: current status and future directions
- (2020) John L. Pfail et al. WORLD JOURNAL OF UROLOGY
- The Role of 18F-FDG PET/CT in Guiding Precision Medicine for Invasive Bladder Carcinoma
- (2020) Antoine Girard et al. Frontiers in Oncology
- Radical Cystectomy Against Intravesical BCG for High-Risk High-Grade Nonmuscle Invasive Bladder Cancer: Results From the Randomized Controlled BRAVO-Feasibility Study
- (2020) James W. F. Catto et al. JOURNAL OF CLINICAL ONCOLOGY
- Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
- (2020) Stephen A Boorjian et al. LANCET ONCOLOGY
- Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 Trial
- (2020) Syed A. Hussain et al. EUROPEAN UROLOGY
- Side Effects of Intravesical BCG and Chemotherapy for Bladder Cancer: What They Are and How to Manage Them
- (2020) George E. Koch et al. UROLOGY
- What is the Standard of Care for Pelvic Lymphadenectomy Performed at the Time of Radical Cystectomy?
- (2019) Seth P. Lerner et al. EUROPEAN UROLOGY
- Meta-analysis of efficacy and safety of continuous saline bladder irrigation compared with intravesical chemotherapy after transurethral resection of bladder tumors
- (2019) Zhongbao Zhou et al. WORLD JOURNAL OF UROLOGY
- SIU–ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer
- (2019) Jeffrey J. Leow et al. WORLD JOURNAL OF UROLOGY
- Comparaison des classifications TNM des 8es éditions de l’UICC et de l’AJCC en uropathologie
- (2019) Eva Compérat et al. ANNALES DE PATHOLOGIE
- Organ preservation in bladder cancer: an opportunity for truly personalized treatment
- (2019) Yee Pei Song et al. Nature Reviews Urology
- Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma
- (2019) Yohann Loriot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiparametric MRI for Bladder Cancer: Validation of VI-RADS for the Detection of Detrusor Muscle Invasion
- (2019) Huanjun Wang et al. RADIOLOGY
- European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update
- (2019) Marko Babjuk et al. EUROPEAN UROLOGY
- A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
- (2019) Aurélie Kamoun et al. EUROPEAN UROLOGY
- EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†
- (2019) J. Alfred Witjes et al. EUROPEAN UROLOGY
- Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
- (2019) Thomas Powles et al. NATURE MEDICINE
- Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer
- (2019) Ryan L. Steinberg et al. JOURNAL OF UROLOGY
- Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System)
- (2018) Valeria Panebianco et al. EUROPEAN UROLOGY
- Vesical Imaging-Reporting and Data System (VI-RADS): Added Value for Management of Bladder Cancer Patients?
- (2018) Harriet C. Thoeny et al. EUROPEAN UROLOGY
- Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications
- (2018) Daniel H. Hovelson et al. EUROPEAN UROLOGY
- Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non–Muscle-Invasive Bladder Cancer on Tumor Recurrence
- (2018) Edward M. Messing et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project
- (2018) Rodolfo Hurle et al. JOURNAL OF UROLOGY
- Discordant molecular subtype classification in the basal-squamous subtype of bladder tumors and matched lymph-node metastases
- (2018) Gottfrid Sjödahl et al. MODERN PATHOLOGY
- A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort
- (2018) Nour-al-dain Marzouka et al. Scientific Reports
- Intratumoral Heterogeneity of Bladder Cancer by Molecular Subtypes and Histologic Variants
- (2018) Joshua I. Warrick et al. EUROPEAN UROLOGY
- Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial
- (2018) Jürgen E. Gschwend et al. EUROPEAN UROLOGY
- Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study
- (2018) Andrea Necchi et al. JOURNAL OF CLINICAL ONCOLOGY
- Perioperative Intravesical Chemotherapy for Patients WithNon–Muscle-invasive Bladder Cancer: Understanding the Extent of and Sources of Variation in Guideline-recommended Use
- (2018) Devon K. Check et al. UROLOGY
- Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
- (2017) Sebastien Antoni et al. EUROPEAN UROLOGY
- Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
- (2017) Roland Seiler et al. EUROPEAN UROLOGY
- Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa–pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?
- (2016) Richard J. Sylvester et al. EUROPEAN UROLOGY
- EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin
- (2016) Samantha Cambier et al. EUROPEAN UROLOGY
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
- (2016) Holger Moch et al. EUROPEAN UROLOGY
- Definitions, End Points, and Clinical Trial Designs for Non–Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group
- (2016) Ashish M. Kamat et al. JOURNAL OF CLINICAL ONCOLOGY
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- (2016) Jonathan E Rosenberg et al. LANCET
- Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis
- (2016) Ming Yin et al. ONCOLOGIST
- The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing
- (2015) T. Helsten et al. CLINICAL CANCER RESEARCH
- Best Practices in Robot-assisted Radical Cystectomy and Urinary Reconstruction: Recommendations of the Pasadena Consensus Panel
- (2015) Timothy G. Wilson et al. EUROPEAN UROLOGY
- Genomic Characterization of Upper Tract Urothelial Carcinoma
- (2015) John P. Sfakianos et al. EUROPEAN UROLOGY
- Improving Selection Criteria for Early Cystectomy in High-Grade T1 Bladder Cancer: A Meta-Analysis of 15,215 Patients
- (2015) William Martin-Doyle et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233
- (2014) Raymond H. Mak et al. JOURNAL OF CLINICAL ONCOLOGY
- Defining and Treating the Spectrum of Intermediate Risk Nonmuscle Invasive Bladder Cancer
- (2014) Ashish M. Kamat et al. JOURNAL OF UROLOGY
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- Metastases in Normal-sized Pelvic Lymph Nodes: Detection with Diffusion-weighted MR Imaging
- (2014) Harriet C. Thoeny et al. RADIOLOGY
- Toward a Molecular Pathologic Classification of Urothelial Carcinoma
- (2013) Gottfrid Sjödahl et al. AMERICAN JOURNAL OF PATHOLOGY
- ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder
- (2012) Georgios Gakis et al. EUROPEAN UROLOGY
- Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer
- (2012) Nicholas D. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial
- (2011) JOURNAL OF CLINICAL ONCOLOGY
- A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy
- (2011) Matthew D Galsky et al. LANCET ONCOLOGY
- LIFE AND DEATH OF SPARE (SELECTIVE BLADDER PRESERVATION AGAINST RADICAL EXCISION): REFLECTIONS ON WHY THE SPARE TRIAL CLOSED
- (2010) Robert A. Huddart et al. BJU INTERNATIONAL
- Differential Complication Rates Following Radical Cystectomy in the Irradiated and Nonirradiated Pelvis
- (2009) Vijay A.C. Ramani et al. EUROPEAN UROLOGY
- Randomized Phase II/III Trial Assessing Gemcitabine/ Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy: Phase II—Results of EORTC Study 30986
- (2009) Maria De Santis et al. JOURNAL OF CLINICAL ONCOLOGY
- Late Pelvic Toxicity After Bladder-Sparing Therapy in Patients With Invasive Bladder Cancer: RTOG 89-03, 95-06, 97-06, 99-06
- (2009) Jason A. Efstathiou et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started